Home
About Us
Cognition
Pipeline
News
Talent
Contact
中
Industry Trends
Technological Frontier
Information of YuanVore
Location：
Home
>
News
>
Industry Trends
Recently, the Drug examination Center (CDE) of the State Drug Administration has accepted a total of 87 mesenchymal stem cell-related drugs and 59 implied clinical permits.
23
2024-04
2024-04-23
In April 2024, the Drug examination Center of the State Drug Administration (CDE) accepted a total of 2 new stem cell-related drugs with implied clinical license.
22
2024-04
2024-04-22
Shenyang successfully obtains "international visa" for cord blood and adult stem cells
17
2024-04
2024-04-17
Review of Stem Cell Policy at a Glance (Updated policy 2023 and 2024)
10
2024-04
2024-04-10
The latest development! Stem cells open up a new era of organoids
09
2024-04
2024-04-09
Diabetic foot amputation is finally unnecessary, and stem cell therapy is expected to help patients get rid of diabetic foot completely
08
2024-04
2024-04-08
Focus on stem cells! The National Two Sessions, Science and Technology Daily, and the Health Commission clearly support the development of the stem cell industry
07
2024-04
2024-04-07
The same stem cells, but they are different: the field of stem cell therapy is very different
02
2024-04
2024-04-02
Prev
...
14
15
16
17
18
...
Next
